112 related articles for article (PubMed ID: 2803923)
1. Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow.
Bettan-Renaud L; de Vathaire F; Bénard J; Morardet N; Pauzie N; Bayet S; Hartmann O; Parmentier C
Br J Cancer; 1989 Oct; 60(4):529-32. PubMed ID: 2803923
[TBL] [Abstract][Full Text] [Related]
2. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
[TBL] [Abstract][Full Text] [Related]
3. Dye-mediated photosensitization of murine neuroblastoma cells.
Sieber F; Sieber-Blum M
Cancer Res; 1986 Apr; 46(4 Pt 2):2072-6. PubMed ID: 3512078
[TBL] [Abstract][Full Text] [Related]
4. The role of reactive oxygen compounds derived from 6-hydroxydopamine for bone marrow purging from neuroblastoma cells.
Bruchelt G; Buck J; Girgert R; Treuner J; Niethammer D
Biochem Biophys Res Commun; 1985 Jul; 130(1):168-74. PubMed ID: 2992460
[TBL] [Abstract][Full Text] [Related]
5. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
Skala JP; Rogers PC; Chan KW; Chao HY; Rodriguez WC
Prog Clin Biol Res; 1992; 377():71-8. PubMed ID: 1438447
[No Abstract] [Full Text] [Related]
6. Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant.
Reynolds CP; Reynolds DA; Frenkel EP; Smith RG
Cancer Res; 1982 Apr; 42(4):1331-6. PubMed ID: 7037175
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
[TBL] [Abstract][Full Text] [Related]
8. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
Yamazaki T; Sato Y; Sieber F
Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
[TBL] [Abstract][Full Text] [Related]
9. Differential binding of soybean agglutinin to human neuroblastoma cell lines: potential application to autologous bone marrow transplantation.
Reisner Y; Gan J
Cancer Res; 1985 Sep; 45(9):4026-31. PubMed ID: 2411394
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
Lemoli RM; Gulati SC
Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
[TBL] [Abstract][Full Text] [Related]
11. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
Beran M; Andersson BS; Wang Y; McCredie KB; Farquhar D
Cancer Res; 1988 Jan; 48(2):339-45. PubMed ID: 3275495
[TBL] [Abstract][Full Text] [Related]
12. Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation.
Sieber F; Rao S; Rowley SD; Sieber-Blum M
Blood; 1986 Jul; 68(1):32-6. PubMed ID: 3521764
[TBL] [Abstract][Full Text] [Related]
13. Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.
Saarinen UM; Coccia PF; Gerson SL; Pelley R; Cheung NK
Cancer Res; 1985 Nov; 45(11 Pt 2):5969-75. PubMed ID: 2414004
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
15. In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation.
Saarinen UM; Wikström S; Mäkipernaa A; Lanning M; Perkkiö M; Hovi L; Rapola J; Sariola H
J Clin Oncol; 1996 Oct; 14(10):2791-802. PubMed ID: 8874341
[TBL] [Abstract][Full Text] [Related]
16. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
Philip T; Ladenstein R; Zucker JM; Pinkerton R; Bouffet E; Louis D; Siegert W; Bernard JL; Frappaz D; Coze C
Br J Cancer; 1993 Jan; 67(1):119-27. PubMed ID: 8427772
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the usefulness of the photodynamic reaction for the purging of bone marrow from metastatic neuroblastoma cells.
Köhler A; Müller A; Zintl F
J Photochem Photobiol B; 1993 Aug; 19(3):227-9. PubMed ID: 8229464
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654].
Urban C; Slace I; Kaulfersch W; Greinix H; Höcker P
Padiatr Padol; 1986; 21(3):275-82. PubMed ID: 3534689
[TBL] [Abstract][Full Text] [Related]
19. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
20. Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts.
Anderson GS; Tsujino I; Miyagi K; Sampson R; Sieber F
J Photochem Photobiol B; 2003 Feb; 69(2):87-95. PubMed ID: 12633981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
